Balyasny Asset Management
ACHL

Balyasny Asset Management’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History

Balyasny Asset Management’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,059
Closed -$39K – 2827
2022
Q3 		$39K Buy
+17,059
New +$39K ﹤0.01% 2013